Significant Agreements (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Significant Agreements (Details) [Line Items]
Annual license maintenance fees, description	The Company will pay annual license maintenance fees, beginning on the first anniversary of the effective date of the agreement and ending upon the first commercial sale of a product, method, or service in the licensed field of use, as follows: $25,000 for each first and second year, $35,000 for each third and fourth year, and $50,000 at each anniversary thereafter ending upon the first commercial sale. The Company is also obligated to pay late-stage clinical development milestones and first commercial sales milestone payments of up to $9.0 million in total. The Company will also pay low single-digit royalties on net sales of licensed products, if approved. The Company paid a $25,000 license maintenance fee in each of March 2023 and 2022, which was recognized as research and development expense in the condensed statements of operations and comprehensive loss for the three months ended March 31, 2023 and 2022.
ISRA [Member]
Significant Agreements (Details) [Line Items]
Option exercise fee	$ 1.0